Skip to main content

Table 6 Amino acids which involved in interactions between FGFR3 protein and candidate ligands before and after molecular dynamics using Ligplot

From: Discovery of potential FGFR3 inhibitors via QSAR, pharmacophore modeling, virtual screening and molecular docking studies against bladder cancer

Type of molecules

Before MD

After MD

DG

H-bonds

(length in Ã…)

Hydrophobic bonds

Active site interaction

DG

H-bonds

(length in Ã…)

Hydrophobic bonds

Active site interaction

Drug

Ponatininb

− 5.20

–

Leu510,Asp518,Leu522,Phe483,Lys649,Thr651,Lys650,Pro657,Val658,Asp646,Tyr647,Met661,Leu645,Tyr671,Asn644,Asp641,Met509,Gly484

−

− 8.97

Asn644(2.96)

Lys517,Phe483,Cys482,Asp641,Val642,Met661,Val658,Asp646,Lys650,Lys649

−

Pemigatinib

− 5.18

–

Leu522, Phe483, Leu510, Gly484, Asp518, Asp521, Leu638, Asp641, Ala639, Arg640, Arg616, Asn644, Lys508, Gln485

Asp617,Leu624,His615,Arg616

− 9.35

–

Pro657,Asp617,Asp635,Ala634,Asn622,Leu624,Leu478,His615,Cys482,Leu638,Asn644,Arg616,Tyr671

Asp617,Leu624,His615,Arg616

Infigratinib

− 5.15

–

Met509, Leu510, Phe483, Asp518, Leu522, Gly484, Asp521, Leu638, His615, Asp635, Asp617, Met661, Leu645, Tyr671, Arg616, Arg640

Leu624

− 8.32

–

Glu556,Ala506,Leu478,Gly479,Glu480,Glu485,Gly481,Cys482,Asp518,Asp521,Gly484,Val486,Lys508,Val555,Leu624

Leu624

Nintedanib

− 5.21

Asp635(3.18), Lys508(3.22), Glu556(2.88), Ala558(3.06)

Val555, Ile539, Gly479, Leu478, Val486, Asn562,Glu565, Gly561, Leu624, Ala506, Tyr557, Glu525, Met529, Ala634

−

− 9.82

Ala558(3.20),Glu556(3.07)

Met529,Ile539,Ala634,Val486,Gly479,Leu478,Gly561,Lys560,Arg570,Ala506,Tyr557,Val555

−

Final selected ligands

Zinc00668789

− 5.11

Thr652(2.97)

Phe636, Ala634, Ile539, Asp635, Val555, Leu624, Tyr557, Ala558, Leu478, Glu565, Asn562, Arg564, Gly479, Thr651, Glu525, Lys508

Leu624

− 10.26

Asp635(2.83)

Phe636,Gly637,Ala634,Gly479,Glu480,Thr652,Asn653,Leu478,Asn562,Leu624,Glu556,Ile539

Leu624

Zinc00702764

− 5.09

–

Tyr671, Arg640, Arg616, Leu638, Lys649, Asp617, Asp646, Tyr647, Val658, Asn644, Pro657, Met661, Leu645

Asp617,Asn622,His615,Arg616

-10.69

–

Ala639,Cys482,Asp617,Asn622,His615,Thr651,Lys649,Lys650,Asn644,Leu645,Tyr671,Asp641,Arg616

Asp617,Asn622,His615,Arg616

Zinc00710252

− 5.06

–

Leu510, Asp518, Gly484, Phe483, Lys508, Leu638, Asn622, His615, Asp617, Asp635, Asn644, Ala639, Asp521, Leu522

Asp617,Arg616

− 10.53

Asn644(2.94)

Val642,Asp641,Phe483,Ala639,Asp518,Leu522,Asp521,Cys482,Leu645,Pro657,Asp617,Leu638,Arg616

Asp617,Arg616

Zinc08433190

− 5.03

Asp635(2.85)

Leu522, Leu510, Leu638, Lys508, Val486, Tyr557, Leu478, Ala558, Ala506, Leu624,Val555, Asp518, Gly484, Asp521, Phe483

Leu624

− 9.69

–

Ala558,Leu478,Leu624,Gly481,Leu522,Met509,Gly484,Gln485,Val486,Glu480,Gly479,Leu638,Tyr557

Leu624

Zinc09045651

− 5.15

–

Met661, Pro657, Arg616, Asp617, Ala639, Leu638, Asn644, Tyr671, Asp646, Leu645

Asp617,Asn622,Arg616

− 10.04

–

Asp641,Leu645,Ala639,Leu638,Asn622,Asp617,Arg640,Arg616,Met661,Tyr671

Asp617,Asn622,Arg616